4 minGlofitamab receives accelerated approval for relapsed or refractory large B-Cell lymphomasIn the world where medical breakthroughs seem to be happening at an unprecedented pace.
3 minEZH2 inhibition with valemetostat: A new frontier in non-hodgkin lymphoma treatmentNon-Hodgkin lymphoma (NHL) is a diverse group of blood cancers that originate in the lymphatic system.
4 minImmuno-PET in Non-Hodgkin lymphoma: A promising diagnostic advancementNon-Hodgkin lymphoma (NHL) is a heterogeneous group of blood cancers that affect the lymphatic system, particularly the lymphocytes.
